INS and Hyperglycemia: Both the direct and the indirect maternal and neonatal benefits demonstrated that pregnant women with diabetes or mild hyperglycemia treated with diet and insulin therapy were less likely to achieve glycemic control, and therefore benefited less than those managed in an outpatient setting.